Vantage Consulting Group’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,343
Closed -$42K 231
2022
Q3
$42K Sell
17,343
-475
-3% -$1.58K 0.02% 209
2022
Q2
$40K Buy
+17,818
New +$66.4K 0.02% 213
2021
Q1
Sell
-9,126
Closed -$97K 1727
2020
Q4
$97K Buy
+9,126
New +$82.9K 0.01% 196

Other funds holding DBD

Vantage Consulting Group's DBD Position: Q4 2022 in Review

Vantage Consulting Group sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2022, closing a stake of 17,343 shares — an estimated $42K sold.

Vantage Consulting Group first reported a position in DBD in Q4 2020 and held it in 3 quarters. The position peaked at $97K in Q4 2020. 148 funds tracked by Wall St. Rank hold DBD as of Q4 2022.

  • Vantage Consulting Group reported no remaining Diebold Nixdorf Incorporated position as of Q4 2022 after selling out during the quarter.
  • Vantage Consulting Group sold 17,343 Diebold Nixdorf Incorporated shares in Q4 2022, an estimated $42K.
  • Vantage Consulting Group first reported a position in Diebold Nixdorf Incorporated in Q4 2020 and held it in 3 quarters.
  • Vantage Consulting Group's Diebold Nixdorf Incorporated position peaked at $97K in Q4 2020.
  • 148 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2022.

Based on Vantage Consulting Group's 13F filing for Q4 2022, filed 13 Feb 2023.